Home › Trial NCT00005980
Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
- Trial IDNCT00005980
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
- Enrollment116
- Start date2000-04
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.